ReviewWorld journal of hepatology2015
Focal liver lesions: Practical magnetic resonance imaging approach.
Review in World journal of hepatology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 34 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
34 citing papers in PubMed, 81 citations in OpenAlex.
- A knowledge-guided dual-path framework for automated liver MRI series classification.Abdominal radiology (New York) · 2026Article
- Focal "Targetoid" liver lesions on MRI: a diagnostic and practical imaging approach.Abdominal radiology (New York) · 2026Review
- Screening Sonography Detection of Liver Masses: Assessing the Non-emergent Nature of Focal Nodular Hyperplasia.Cureus · 2026Article
- Deep learning-based MRI model for predicting P53-mutated hepatocellular carcinoma.BMC medical imaging · 2025Article
- Hyperechogenicity and histopathological features of focal liver lesions.Journal of medical ultrasonics (2001) · 2025Review
- MRI-compatible abdomen phantom to mimic respiratory-triggered organ movement while performing needle-based interventions.International journal of computer assisted radiology and surgery · 2024Article
- WFUMB Review Paper. Incidental Findings in Otherwise Healthy Subjects, How to Manage: Liver.Cancers · 2024Review
- Hepatocellular adenomas with severe intra-abdominal bleeding, related to an underlying coagulation disorder: a case report.Journal of medical case reports · 2024Article
- Comparative analysis of the performance of hepatobiliary agents in depicting MRI features of microvascular infiltration in hepatocellular carcinoma.Abdominal radiology (New York) · 2024Article
- Article
- Liver metastases: The role of magnetic resonance imaging.World journal of gastroenterology · 2023Review
- Manganese (II) Complex of 1,4,7-Triazacyclononane-1,4,7-Triacetic Acid (NOTA) as a Hepatobiliary MRI Contrast Agent.Pharmaceuticals (Basel, Switzerland) · 2023Article
- Article
- Microvascular flow imaging to differentiate focal hepatic lesions: the spoke-wheel pattern as a specific sign of focal nodular hyperplasia.Ultrasonography (Seoul, Korea) · 2023Article
- FI-CEUS: a solution to improve the diagnostic accuracy in MRI LI-RADS-indeterminate (LR-3/4) FLLs at risk for HCC.Frontiers in oncology · 2023Article
- Focal Liver Lesion MRI Feature Identification Using Efficientnet and MONAI: A Feasibility Study.Cells · 2022Article
- Congenital extrahepatic portosystemic shunt type II occluded with cardiac closure device.Radiology case reports · 2021Article
- Saliency-based 3D convolutional neural network for categorising common focal liver lesions on multisequence MRI.Insights into imaging · 2021Article
- Automatic discrimination of different sequences and phases of liver MRI using a dense feature fusion neural network: a preliminary study.Abdominal radiology (New York) · 2021Article
- Diagnosis of focal liver lesions with deep learning-based multi-channel analysis of hepatocyte-specific contrast-enhanced magnetic resonance imaging.World journal of gastroenterology · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
With the widespread of cross-sectional imaging, a growth of incidentally detected focal liver lesions (FLL) has been observed. A reliable detection and characterization of FLL is critical for optimal patient management. Maximizing accuracy of imaging in the context of FLL is paramount in avoiding unnecessary biopsies, which may result in post-procedural complications. A tremendous development of new imaging techniques has taken place during these last years. Nowadays, Magnetic resonance imaging (MRI) plays a key role in management of liver lesions, using a radiation-free technique and a safe contrast agent profile. MRI plays a key role in the non-invasive correct characterization of FLL. MRI is capable of providing comprehensive and highly accurate diagnostic information, with the additional advantage of lack of harmful ionizing radiation. These properties make MRI the mainstay for the noninvasive evaluation of focal liver lesions. In this paper we review the state-of-the-art MRI liver protocol, briefly discussing different sequence types, the unique characteristics of imaging non-cooperative patients and discuss the role of hepatocyte-specific contrast agents. A review of the imaging features of the most common benign and malignant FLL is presented, supplemented by a schematic representation of a simplistic practical approach on MRI.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.